Modular Medical CFO acquires option for 150,000 shares

One-third of the option vests on October 29, 2027, followed by monthly vesting of one thirty-sixth of the shares.

Available on EDGAR 11/09/2026 - 09:58 PM EST Accepted by SEC EDGAR 11/09/2026 - 09:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Modular Medical, Inc. (MODD) reported that Director and President, Chief Financial Officer and Treasurer Paul DiPerna acquired a direct option to purchase 150,000 shares of common stock on October 29, 2026. The option has an exercise price of $1.72 per share and expires October 29, 2036.

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider DiPerna Paul

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock F1, F2	150,000	$0.00	$0.00

Holdings After Transaction: Option to purchase common stock — 150,000 options (Direct)

Holdings Before and After: Option to purchase common stock, 0 to 150,000 options (Direct)

Footnotes (2)

1. F1. This option shall vest as to 1/3rd of the shares subject to the option on October 29, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.
2. F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Option shares: 150,000 shares Exercise price: $1.72 per share Grant date: October 29, 2026 +2 more

5 metrics

Option shares 150,000 shares Option to purchase common stock acquired by Paul DiPerna

Exercise price $1.72 per share Option acquired October 29, 2026

Grant date October 29, 2026 Option acquisition

First vesting date October 29, 2027 One-third of the shares subject to the option vest on this date

Option expiration date October 29, 2036 Expiration of the option

Key Terms

Option to purchase common stock, exercise price, vest

3 terms

Option to purchase common stock financial

"Option to purchase common stock"

exercise price financial

"exercise price of $1.72 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"shall vest as to 1/3rd of the shares"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MODD shares does Paul DiPerna's option cover, and what is the exercise price?

Paul DiPerna's option covers 150,000 shares of common stock and has an exercise price of $1.72 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DiPerna Paul

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$1.72	10/29/2026		A		150,000		(1)	10/29/2036	Common Stock	150,000	$0.00	150,000(2)	D

Explanation of Responses:

1. This option shall vest as to 1/3rd of the shares subject to the option on October 29, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Remarks:

President, Chief Financial Officer and Treasurer

	/s/ James Sullivan, attorney-in-fact for Paul DiPerna	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)